Citius Pharmaceuticals In... (CTXR)
undefined
undefined%
At close: undefined
3.89
5.14%
After-hours Jan 08, 2025, 06:27 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11
Cash & Equivalents 3.25M 26.48M 41.71M 70.07M 13.86M 7.89M 9.18M 3.20M 294.35K 676.14K 1.55M 54.39K 135.00 212.00
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a 29.18M 16.92M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 92.84M 38.06K 39.97M 38.06K 57.09K 57.09K 2.17K 2.17K 66.97K n/a n/a n/a -5.4 n/a
Receivables n/a n/a n/a n/a n/a n/a 818.34K n/a n/a n/a n/a n/a n/a n/a
Inventory 8.27M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 2.70M 7.89M 2.85M 2.74M 122.24K 48.11K 57.73K 220.25K 598.48K 60.00K n/a 48.17K n/a n/a
Total Current Assets 14.22M 34.37M 44.56M 72.81M 13.98M 7.94M 10.06M 3.42M 892.84K 736.14K 1.55M 102.56K 135.00 212.00
Property-Plant & Equipment 246.25K 455.86K 650.17K 829.85K 987.78K 590.00 1.48K 3.24K 3.74K n/a n/a n/a n/a n/a
Goodwill & Intangibles 9.35M 68.75M 68.75M 68.75M 28.75M 20.99M 20.99M 20.99M 20.99M 5.40K 5.40K 5.40K 5.40 n/a
Total Long-Term Assets 102.43M 69.24M 69.44M 69.61M 29.79M 21.04M 20.99M 20.99M 21.06M 5.40K 5.40K 5.40K 5.40 n/a
Total Assets 116.65M 103.61M 114.00M 142.43M 43.77M 28.99M 31.05M 24.42M 21.95M 741.54K 1.56M 107.97K 135.00 212.00
Account Payables 4.93M 2.93M 1.17M 1.28M 1.86M 2.71M 1.57M 602.43K 909.16K 559.15K 106.17K 11.47K n/a 906.00
Deferred Revenue n/a n/a n/a n/a n/a n/a n/a n/a 1.92M n/a 142.28K n/a -97.39 n/a
Short-Term Debt 241.55K 218.38K 393.98K 354.47K 490.97K 172.97K 172.97K 172.97K 672.97K n/a 600.00K 3.21K n/a n/a
Other Current Liabilities 30.65M 2.63M 2.97M 2.35M 1.75M 1.72M 1.44M 1.69M 3.60M 817.60K 1.59M 11.00 45.98K 23.15K
Total Current Liabilities 35.81M 5.78M 4.53M 3.98M 4.10M 4.61M 3.18M 2.47M 5.18M 1.38M 2.30M 14.69K 45.98K 24.05K
Long-Term Debt 21.32K 262.87K 481.25K 678.23K 1.02M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities 6.74M 6.40M 6.04M 5.66M 6.01M 4.99M 1.75M n/a n/a n/a n/a 1.69M 1.46K n/a
Total Liabilities 42.55M 12.18M 10.57M 9.65M 10.10M 4.61M 3.18M 2.47M 5.18M 1.38M 2.30M 14.69K 45.98K 24.05K
Total Debt 262.87K 481.25K 678.23K 855.47K 1.35M 172.97K 172.97K 172.97K 672.97K n/a 600.00K 3.21K 17.05K 18.49K
Common Stock 7.25K 158.86K 146.21K 145.98K 55.58K 28.93K 16.20K 8.35K 73.14K 34.12K 30.02K 18.00K 18.00K 18.00K
Retained Earnings -201.37M -162.23M -129.69M -96.05M -70.59M -55.82M -40.26M -27.72M -17.34M -9.04M -6.14M -95.22K -63.85K -41.84K
Comprehensive Income n/a n/a n/a n/a 0.00 n/a 0.00 0.00 n/a n/a n/a n/a n/a n/a
Shareholders Equity 70.08M 90.83M 102.83M 132.18M 33.67M 24.38M 27.87M 21.95M 16.77M -635.21K -741.93K -14.69K -45.85K -23.84K
Total Investments n/a n/a n/a 29.18M 16.92M n/a n/a n/a n/a n/a n/a n/a n/a n/a